In 2 recently published studies from Germany and the UK (2,5), the infection rates observed in the anti-TNFα cohorts were very similar, but the 2 groups of investigators drew very different conclusions, the former estimating a doubling of risk and the latter no increased risk. The gene discussed is TNF; the disease is infection.